MDDVF (Medical Developments International) Cyclically Adjusted FCF per Share: $-0.06 (As of Dec. 2025)


MDDVF Medical Developments International Ltd MDDVF
51 GF Score
Price $0.37
GF Value $0.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Cyclically Adjusted FCF per Share?

Medical Developments International MDDVF 51 Cyclically Adjusted FCF per Share is $-0.06 as of Dec. 2025. GuruFocus rates MDDVF with a GF Score™ of 51/100 and a GF Value™ of $0.39 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Medical Developments International's adjusted free cash flow per share data for the fiscal year that ended in Jun. 2025 was $-0.006. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.06 for the trailing ten years ended in Jun. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Medical Developments International was 26.00% per year. The lowest was -49.40% per year. And the median was -10.30% per year.

As of today (2026-07-01), Medical Developments International's current stock price is $ 0.37. Medical Developments International's Cyclically Adjusted FCF per Share for the fiscal year that ended in Jun. 2025 was $-0.06. Medical Developments International's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medical Developments International was 527.24. The lowest was 201.31. And the median was 270.81.


Medical Developments International  (OTCPK:MDDVF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medical Developments International was 527.24. The lowest was 201.31. And the median was 270.81.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Medical Developments International Cyclically Adjusted FCF per Share Related Terms


Medical Developments International Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Medical Developments International's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International Cyclically Adjusted FCF per Share Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.06 -0.06 -0.07 -0.06

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.07 0.00 -0.06 0.00

MDDVF vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medical Developments International's Cyclically Adjusted Price-to-FCF falls into.


MDDVF
51GF Score
Medical Developments International Ltd MDDVF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Developments International Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medical Developments International's adjusted Free Cash Flow per Share data for the fiscal year that ended in Jun. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=-0.006/131.5506*131.5506
=-0.006

Current CPI (Jun. 2025) = 131.5506.

Medical Developments International Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.097 0.000
201706 -0.058 0.000
201806 -0.108 0.000
201906 0.117 0.000
202006 -0.088 0.000
202106 -0.165 0.000
202206 -0.151 0.000
202306 -0.192 0.000
202406 -0.105 0.000
202506 -0.006 131.551 -0.006

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.06 mean?
Medical Developments International (MDDVF) has a Cyclically Adjusted FCF per Share of $-0.06 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medical Developments International and its competitors.
Is Medical Developments International's Cyclically Adjusted FCF per Share too high?
Medical Developments International's current Cyclically Adjusted FCF per Share is $-0.06. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Medical Developments International's Cyclically Adjusted FCF per Share of $-0.06 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medical Developments International and its competitors. Medical Developments International's current Cyclically Adjusted FCF per Share is $-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (MDDVF) is currently considered Fairly Valued. The stock's GF Value™ is $0.39, compared to a current price of $0.37 — trading 5.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-0.06. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Medical Developments International (MDDVF), the current Cyclically Adjusted FCF per Share is $-0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (MDDVF) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of $0.37 is trading 5.1% below its estimated GF Value™ of $0.39. GuruFocus considers Medical Developments International to be Fairly Valued.

Key valuation signals for MDDVF:

  • Cyclically Adjusted FCF per Share: $-0.06
  • GF Value™: $0.39 vs. price of $0.37 (5.1% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the MDDVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Developments International Business Description

Other Exchanges M5D:GermanyMVP:Australia
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score

Get the complete analysis for MDDVF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.39
GF Value